Author Correction: HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Main Authors: | Chao Liang, Jie Li, Cheng Lu, Duoli Xie, Jin Liu, Chuanxin Zhong, Xiaohao Wu, Rongchen Dai, Huarui Zhang, Daogang Guan, Baosheng Guo, Bing He, Fangfei Li, Xiaojuan He, Wandong Zhang, Bao-Ting Zhang, Ge Zhang, Aiping Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-16901-6 |
Similar Items
-
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
by: Chao Liang, et al.
Published: (2019-10-01) -
Effect of CRP and Kinetics of CRP in Prognosis of Nasopharyngeal Carcinoma
by: Ruiwan Chen, et al.
Published: (2019-02-01) -
Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial
by: Chi Zhang, et al.
Published: (2019-08-01) -
C-reactive protein (CRP) and anti-CRP autoantibodies in systemic lupus erythematosus : a study on the occurrence and clinical implications of anti-CRP antibodies and CRP-mediated complement activation
by: Sjöwall, Christopher
Published: (2006) -
CRP in Relation To CVD
by: J. Vimalin Hena, et al.
Published: (2010-10-01)